Central Venous Access for Chemotherapy

Jun 19, 2016 by in ONCOLOGY Comments Off on Central Venous Access for Chemotherapy

Central Venous Access for Chemotherapy Michael B. Nicholl Paul S. Dale Despite remarkable achievements in cancer prevention, detection, and treatment, cancer is still the second leading cause of death in…

read more

Chemotherapy in Pregnancy

Jun 19, 2016 by in ONCOLOGY Comments Off on Chemotherapy in Pregnancy

Chemotherapy in Pregnancy Monique A. Hartley-Brown Donald C. Doll Cancer during pregnancy is fairly uncommon. It is the leading cause of death in women of childbearing age with an incidence…

read more

Second Malignancies after Chemotherapy

Jun 19, 2016 by in ONCOLOGY Comments Off on Second Malignancies after Chemotherapy

Second Malignancies after Chemotherapy Daniel J. Becker Thomas S. Uldrick Alfred I. Neugut The era of modern chemotherapy traces back to the 1940s when it was discovered that the nitrogen…

read more

Vascular Toxicity of Antineoplastic Agents

Jun 19, 2016 by in ONCOLOGY Comments Off on Vascular Toxicity of Antineoplastic Agents

Vascular Toxicity of Antineoplastic Agents Ravi K. Bobba Donald C. Doll The association of venous thromboembolism (VTE) with underlying malignancy is well known; thereby screening for an occult malignancy in…

read more

Chemotherapy-Induced Peripheral Neuropathy

Jun 19, 2016 by in ONCOLOGY Comments Off on Chemotherapy-Induced Peripheral Neuropathy

Chemotherapy-Induced Peripheral Neuropathy Frederick Hausheer Stacey Bain Chemotherapy-induced peripheral neuropathy (CIPN) is a common and serious clinical problem that affects many patients receiving cancer treatment.1,2,3,4 This iatrogenic condition can pose…

read more

Chemotherapy-Induced Renal and Electrolyte Dysfunction

Jun 19, 2016 by in ONCOLOGY Comments Off on Chemotherapy-Induced Renal and Electrolyte Dysfunction

Chemotherapy-Induced Renal and Electrolyte Dysfunction Harbaksh Sangha Ramesh Khanna The chemotherapeutic drugs that are filtered, secreted, and cleared by the kidneys have the potential to cause acute and chronic kidney…

read more

Hepatotoxicity of Chemotherapeutic Agents

Jun 19, 2016 by in ONCOLOGY Comments Off on Hepatotoxicity of Chemotherapeutic Agents

Hepatotoxicity of Chemotherapeutic Agents Ravi K. Bobba Stephen Medlin Michael C. Perry The development of abnormal liver function tests (LFTs) in a patient who is receiving chemotherapy can present a…

read more

Gastrointestinal Complications of Chemotherapy

Jun 19, 2016 by in ONCOLOGY Comments Off on Gastrointestinal Complications of Chemotherapy

Gastrointestinal Complications of Chemotherapy Rashmi Ramasubbaiah Gastrointestinal (GI) side effects are very common with most chemotherapeutic and targeted agents (biologics). Most experts feel that the toxicities are generally underreported.1,2,3 It…

read more

Pulmonary Toxicity of Chemotherapeutic Agents

Jun 19, 2016 by in ONCOLOGY Comments Off on Pulmonary Toxicity of Chemotherapeutic Agents

Pulmonary Toxicity of Chemotherapeutic Agents Vamsi P. Guntur Rajiv Dhand Pulmonary toxicity is recognized with a growing number of chemotherapeutic agents. An estimated 5% to 20% or more of patients…

read more
Get Clinical Tree app for offline access